BioSpace News Archive

China Pharma Holdings, Inc. Launched Health Product Noni Enzyme ARARATO®

China Pharma Holdings, Inc. announced today the launch of its health product Noni Enzyme ARARATO® to the market.

November 13, 2018
·
3 min read
Business

DJO Global Announces Financial Results for Third Quarter 2018

Revenue and Profitability Growth Continue on Strength of Business Transformation

November 13, 2018
·
22 min read
BioForest

BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences

BioLife Solutions, Inc. today announced that management and scientific personnel will be attending and presenting at the following upcoming events:

November 13, 2018
·
3 min read
Business

Dana-Farber Cancer Institute and Deerfield Collaborate to Create the Center for Protein Degradation

The Center for Protein Degradation will build upon the work of Dana-Farber researchers Nathanael Gray, PhD and Eric Fischer, PhD

November 13, 2018
·
4 min read
Business

NeuroStar® Advanced Therapy and Transformations TMS Expanding Partnership to Increase Patient Access to Depression Treatment

TMS therapy provider will be offering NeuroStar Advanced Therapy at six new locations

November 13, 2018
·
4 min read
Policy

athenahealth (ATHN) Alert: Johnson Fistel Investigates Proposed Sale of athenahealth, Inc.; Is $135 a Fair Price?

Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of athenahealth, Inc. breached their fiduciary duties in connection with the proposed sale of the Company to Veritas Capital (“Veritas”) and Evergreen Coast Capital (“Evergreen”).

November 13, 2018
·
1 min read
FDA

Lumendi Receives FDA 510(k) Clearance for Innovative DiLumen™ EIP Device Modification to Improve Tissue Retraction During Therapeutic Endoscopy

Modification Improves Endoscopists’ Ability to Dissect and Ultimately Resect Polyps Without Surgical Intervention

November 13, 2018
·
4 min read
Business

BerGenBio ASA: Results for the Third Quarter 2018

Phase II data in NSCLC with bemcentinib/KEYTRUDA combination: First stage of trial in previously treated patients reported 40% ORR and ca. 6 months median PFS in AXL positive patients, stage 2 actively enrolling patients

November 13, 2018
·
6 min read
Business

GenomOncology announces partnership with Indiana University School of Medicine

GenomOncology to provide clinical researchers with real-time clinical trial matching in support of IU’s Grand Challenge Precision Health Initiative

November 13, 2018
·
2 min read
Business

Horizon Healthcare Services Inc. selects Geneia to accelerate member-centric healthcare

New Jersey’s largest health plan to use Geneia’s Theon® platform to effectively anticipate and meet the diverse needs of its 3.8 million members

November 13, 2018
·
3 min read